Libivirumab is a human monoclonal antibody directed against the hepatitis B virus. Libivirumab had an IC50 of 35 and 128 ng/ml in the neutralization assays based on ELISA and immunofluorescence assays.
Research Grade Libivirumab
Overview
Catalog No.
VK539036
Host species
Human
Species reactivity
Hepatitis B virus genotype A (HBV-A)
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Purity
>95% purity as determined by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1, kappa
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target
Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S
Purification
Protein A/G purified from cell culture supernatant.
Endotoxin level
Please contact the lab for this information.
Expression system
Mammalian Cells
Accession
P03142
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternative name
17.1.41, HepeX-B(combinationofexbivirumabandlibivirumab), 569658-79-3
Note
For research use only. Not suitable for clinical or therapeutic use.
Description
Images
SEC-HPLC
SEC-HPLC detection for Research Grade Libivirumab.
Bioactivity
Detects S/L-HBsAg/L glycoprotein in indirect ELISAs.
SDS-PAGE
SDS-PAGE for Research Grade Libivirumab.